11 - 13 out of 13Page size: 10
  1. 2011

  2. Nebulized anticoagulants limit coagulopathy but not inflammation in pseudomonas aeruginosa-induced pneumonia in rats

    Cornet, A. D., Hofstra, J. J., Vlaar, A. P., van den Boogaard, F. E., Roelofs, J. J., van der Poll, T., Levi, M., Groeneveld, A. B. J. & Schultz, M. J., 2011, In: Shock (Augusta, Ga.). 36, 4, p. 417-423

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia

    van den Boogaard, F. E., Brands, X., Schultz, M. J., Levi, M. M. M. ., Roelofs, J. J. T. H., van 't Veer, C. & van der Poll, T., 2011, In: Journal of thrombosis and haemostasis. 9, 1, p. 122-132

    Research output: Contribution to journal › Article › Academic › peer-review

  4. 2010

  5. Therapeutic recombinant murine activated protein C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumonia

    Schouten, M., van 't Veer, C., van den Boogaard, F. E., Gerlitz, B., Grinnell, B. W., Roelofs, J. J. T. H., Levi, M. & van der Poll, T., 2010, In: Journal of infectious diseases. 202, 10, p. 1600-1607

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 Next

ID: 92988